AddLife Past Earnings Performance
Past criteria checks 1/6
AddLife has been growing earnings at an average annual rate of 23.8%, while the Life Sciences industry saw earnings growing at 27.2% annually. Revenues have been growing at an average rate of 27.9% per year. AddLife's return on equity is 5.7%, and it has net margins of 3.1%.
Key information
23.8%
Earnings growth rate
21.1%
EPS growth rate
Life Sciences Industry Growth | 36.9% |
Revenue growth rate | 27.9% |
Return on equity | 5.7% |
Net Margin | 3.1% |
Next Earnings Update | 02 Feb 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How AddLife makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 9,467 | 292 | 2,937 | 94 |
30 Jun 23 | 9,248 | 387 | 2,847 | 91 |
31 Mar 23 | 8,962 | 429 | 2,754 | 88 |
31 Dec 22 | 9,084 | 480 | 2,656 | 81 |
30 Sep 22 | 8,889 | 597 | 2,441 | 66 |
30 Jun 22 | 8,639 | 615 | 2,253 | 55 |
31 Mar 22 | 8,836 | 718 | 2,131 | 43 |
31 Dec 21 | 7,993 | 719 | 1,819 | 34 |
30 Sep 21 | 7,593 | 759 | 1,652 | 33 |
30 Jun 21 | 6,984 | 748 | 1,451 | 31 |
31 Mar 21 | 5,956 | 690 | 1,180 | 26 |
31 Dec 20 | 5,273 | 518 | 1,136 | 24 |
30 Sep 20 | 4,530 | 349 | 1,074 | 23 |
30 Jun 20 | 4,091 | 248 | 1,069 | 23 |
31 Mar 20 | 3,687 | 160 | 1,050 | 24 |
31 Dec 19 | 3,479 | 141 | 1,007 | 24 |
30 Sep 19 | 3,176 | 136 | 921 | 23 |
30 Jun 19 | 2,952 | 134 | 844 | 23 |
31 Mar 19 | 2,730 | 138 | 778 | 22 |
31 Dec 18 | 2,482 | 129 | 708 | 20 |
30 Sep 18 | 2,465 | 125 | 710 | 19 |
30 Jun 18 | 2,404 | 123 | 700 | 19 |
31 Mar 18 | 2,354 | 117 | 679 | 18 |
31 Dec 17 | 2,333 | 120 | 667 | 18 |
30 Sep 17 | 2,277 | 129 | 635 | 15 |
30 Jun 17 | 2,169 | 125 | 593 | 10 |
31 Mar 17 | 2,062 | 122 | 558 | 6 |
31 Dec 16 | 1,939 | 112 | 528 | 2 |
30 Sep 16 | 1,799 | 90 | 511 | 0 |
30 Jun 16 | 1,760 | 82 | 501 | 0 |
31 Mar 16 | 1,562 | 78 | 446 | 0 |
31 Dec 15 | 1,394 | 78 | 383 | 0 |
31 Mar 15 | 1,057 | 80 | 289 | 0 |
31 Mar 14 | 984 | 78 | 273 | 0 |
31 Mar 13 | 907 | 74 | 258 | 0 |
Quality Earnings: ALIFBS has a large one-off gain of SEK188.0M impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: ALIFBS's current net profit margins (3.1%) are lower than last year (6.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ALIFBS's earnings have grown significantly by 23.8% per year over the past 5 years.
Accelerating Growth: ALIFBS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ALIFBS had negative earnings growth (-51.1%) over the past year, making it difficult to compare to the Life Sciences industry average (12.2%).
Return on Equity
High ROE: ALIFBS's Return on Equity (5.7%) is considered low.